Join Team CMT – Be a part of finding a cure!

by | Aug 19, 2014 | 2 comments

Team CMT Logo copyTeam CMT is a grassroots community fundraising program founded by Chris Wodke, a CMT athlete that partnered with the Hereditary Neuropathy Foundation (HNF) to raise awareness for Charcot-Marie-Tooth disease. Building awareness helps us to create a better  understanding of the challenges faced by those living with CMT and assists us in increasing support, research, and the likelihood of finding a cure.

You can join us, and truly make a difference. Register to be a Team CMT member and you’ll be part of an international effort to change the future for those living with CMT.

By joining the team and making a minimum donation of $25, we will send you a Team CMT shirt that you can wear to help build awareness. You can wear your Team CMT shirt to the gym, physical therapy, or to an athletic event  If you want you can fundraise too, and have a dedicated fundraising page to track your efforts:

Team CMT is not just for adults. Check out our Team CMT Kids page to learn how to support children living with CMT by registering your school or team:

Thank you for your support…we could not do what we do without you!

Learn more on this topic

Related Blog Posts

Building Awareness on CMT and Supporting the Patient Community – HNF Announces Support from Pharnext

HNFpharnext recently entered into a partnership with the French biopharmaceutical company, Pharnext, to help raise awareness of Charcot-Marie-Tooth (CMT) disease and support the CMT patient community through several initiatives. Building awareness is key! Pharnext’s support will assist HNF in distributing HNF’s CMT Update quarterly newsletter, enhancing the Global Registry for Inherited Neuropathies (GRIN), setting up activities for CMT September Awareness Month in the US and strengthening the CMT Inspire Community.

In Memoriam

The HNF family has lost two great people this summer: Franklin G. Downing Sr. (father of board member Matthew Downing) and George G. Gatta (father of board member Kathleen Zappola).

Targeting PMP22 in CMT1A Patients with Gene Duplication

In previous collaborative work with a group of investigators including Dr Rolf Renne from the University of Florida, Dr. Alex Murashov from East Carolina University and Dr. Lynn Hudson from the NIH-NINDS, we validated a microRNA known as miR29a as a reagent that corrected the expression level of PMP22 in rodent Schwann cells.

Join the conversation

Leave a Comment


  1. Albert Ortiz

    I have CMT. I want receive information.


Submit a Comment

Your email address will not be published. Required fields are marked *


Join for notifications on events, campaigns, & news